World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02221752
Date of registration: 18/08/2014
Prospective Registration: No
Primary sponsor: Zhao gengli
Public title: Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
Scientific title: Impact of Iron/Folic Acid Versus Folic Acid Supplements During Pregnancy on Maternal and Children's Health: A Randomized Controlled Trial in China
Date of first enrolment: June 2009
Target sample size: 2367
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02221752
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Phase:  N/A
Countries of recruitment
China
Contacts
Name:     Zhao Gengli, MD
Address: 
Telephone:
Email:
Affiliation:  Peking University First Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- uncomplicated singleton pregnancy, first enrollment visit = 20 weeks gestation -

Exclusion Criteria:

- < 18 years of age

- did not live in the county

- did not anticipate delivery at participating hospital

- were not mentally competent

- had a chronic health problem or hemoglobin < 100 g/L at the initial visit

- were taking iron at the time.



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Iron Deficiency
Iron Deficiency Anemia
Intervention(s)
Dietary Supplement: Ferrous Sulfate + folic acid
Dietary Supplement: Folic acid
Primary Outcome(s)
Maternal iron status at follow-up prenatal visit [Time Frame: 36-40 weeks]
Maternal iron status at follow-up prenatal visit [Time Frame: 26-30 weeks]
Secondary Outcome(s)
Infant birth weight [Time Frame: delivery]
Infant gestational age [Time Frame: delivery]
Cord-blood iron status [Time Frame: delivery]
Secondary ID(s)
Vifor/PFH supplement trial
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Vifor Inc.
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history